Greater Cannabis Company (GCAN) Interest Coverage Ratio (2017 - 2021)
Greater Cannabis Company's (GCAN) quarterly Interest Coverage Ratio came in at 2.71 in Q4 2021, down 97.61% year-on-year from 113.19 in Q4 2020, and down 97.61% quarter-over-quarter from 1.37 in Q4 2020.
Greater Cannabis Company (GCAN) Interest Coverage Ratio (2017 - 2021) Analysis & Trends
Greater Cannabis Company's Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 2.71 for Q4 2021.
- On a quarterly basis, Interest Coverage Ratio fell 97.61% year-over-year to 2.71 in Q4 2021; TTM through Dec 2021 was 7.74, a 2.64% decrease from a year earlier, with the FY2021 full-year figure at 7.74, down 2.64% from the prior year.
- Interest Coverage Ratio retreated to 2.71 in Q4 2021 per GCAN's latest filing, from 1.37 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 52.33 in Q3 2017 and bottomed at 706.08 in Q1 2017.
- The 4-year median for Interest Coverage Ratio is 1.37 (2020), against an average of 70.6.
- Biggest YoY gain for Interest Coverage Ratio was 132.48% in 2018; the steepest drop was 126.41% in 2018.
- Year by year, Interest Coverage Ratio stood at 10.82 in 2017, then tumbled by 227.7% to 13.82 in 2018, then soared by 90.08% to 1.37 in 2020, then slumped by 97.61% to 2.71 in 2021.
- Per Business Quant, the three latest GCAN Interest Coverage Ratio figures stand at 2.71 (Q4 2021), 1.37 (Q4 2020), and 13.82 (Q3 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -2.71 |
| Dec 31, 2020 | -1.37 |
| Sep 30, 2018 | -13.82 |
| Jun 30, 2018 | 10.06 |
| Mar 31, 2018 | 46.37 |
| Dec 31, 2017 | 10.82 |
| Sep 30, 2017 | 52.33 |
| Jun 30, 2017 | -30.97 |
| Mar 31, 2017 | -706.08 |